Mon, May 11, 2020

John Ransom Maintained (AMED) at Buy with Decreased Target to $210 on, May 11th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-210-on-may-11th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
John Ransom of Raymond James, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $225 to $210 on, May 11th, 2020.

John has made no other calls on AMED in the last 4 months.



There are 3 other peers that have a rating on AMED. Out of the 3 peers that are also analyzing AMED, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $200 on, Friday, February 21st, 2020


These are the ratings of the 2 analyists that currently disagree with John


  • Bill Sutherland of "Benchmark" Upgraded from Hold to Strong Buy and Held Target at $205 on, Monday, March 9th, 2020
  • A.J. Rice of "Credit Suisse" Initiated at Buy and Held Target at $206 on, Friday, January 17th, 2020